NSDIC Showcase to improve quality of care, RMNCH in North-East Nigeria



The National Service Delivery Innovation Challenge (NSDIC) showcase, which is a competitive process to identify, showcase and spur innovations in service delivery is set to improve the quality and coverage of RMNCAH and nutrition interventions across the country – particularly in North-East Nigeria and undeserved populations.

Until now, the North East has been affected by insurgency for over three years which negatively impacted the access to quality of care, routine maternal and neonatal child health care of childhood diseases such as polio, measles, etc. This development has led to the reappearance of the Wild Polio Virus (WPV) in 20116 which has been described as a setback in the wake of the country’s polio eradication and certification as a Polio-free nation by the World Health Organisation (WHO)


His Excellency, Prof. Yemi Osinbajo, Vice-President of the Federal Republic of Nigeria will be the Special Guest of Honour at the NSDIC showcase of shortlisted innovations scheduled to hold tomorrow 12th of January 2017 at the Transcorp Hilton Abuja by 10 am. Dr. Okechukwu E. Enelamah, Honourable Minister of Industry, Trade & Investments will give a lecture with private sector partners such as the World Bank, Private Sector Health Alliance of Nigeria (PHN), Sterling Bank Plc, Healthcare Federation of Nigeria (HFN), and other development partners and stakeholders in the health sector.

Winning entries/ innovations are expected to form part of the Federal Ministry of Health Global Financing Facility (GFF) investment case.

It will be recalled that the Federal Ministry of Health (FMOH) in partnership with the Global Financing Facility, the World Bank Group, Private Sector Health Alliance of Nigeria (PHN), the Healthcare Federation of Nigeria (HFN) and Sterling Bank, issued a Request for Concept Notes (RFCN) to solicit submissions with promising innovations in service delivery to participate in the Nigeria Service Delivery Innovation Challenge (NSDIC).

Comments

Post a Comment

Popular posts from this blog

Unilever named most successful brand among FT500

Image
Unilever has been named as the most successful brand among the FT 500 for meeting its philanthropic goals, according to a recent study by Radley Yeldar. Unilever’s sustainability strategy was found to have made the biggest impact of all the companies listed in the FT 500 and the FTSE Eurofirst 100, having achieved the goals set out in its ‘making sustainable life commonplace’ mission statement. Radley Yeldar ranked the British-Dutch multinational consumer goods company number 1 on its Fit for Purpose Index 2015 which assesses and ranks companies based on how they live up to the altruistic promises set out in their brand purpose. The success of Unilever’s Bright Future project was the main driver behind its number 1 ranking. The ongoing initiative is a partnership with the WWF and promotes sustainable manufacturing of its products and a pledge of zero deforestation in doing so. In assessing the strength and impact of Unilever- whose brands include Dove and Dome
Read more

Nigeria now emerging hub for pharma market expansion in Africa

Image
A s growth opportunities continue to move away from traditional pharmaceutical markets and growth patterns in developed markets continue to flatten, many multinational companies (MNCs) like Norvatis, Pfizer, Sanofi, Johnson & Johnson, etc. look toward Africa, including Nigeria for their expanding global footprint. This is evident following GlaxoSmithKline (GSK) plan to invest over $200million in Africa over the next five years, expanding manufacturing in Nigeria and Kenya and building five new factories-Rwanda, Ghana and Ethiopia given its attractive long-term growth potential. With a growing middle class of expected annual disposable income in excess of $1 trillion by 2023, increasing awareness of healthier lifestyles, and a combined Gross Domestic Product (GDP) of $2.9 trillion, rising population growth is emerging as a melting pot for pharmaceutical expansion. Interestingly, of the four MINT countries (Mexico, Indonesia, Nigeria, and Turkey), Nigeria’s
Read more

WHO unveils list of essential diagnostic tests to improve health outcomes

Image
 Today, many people are unable to get tested for diseases because they cannot access diagnostic services. Many are incorrectly diagnosed. As a result, they do not receive the treatment they need and, in some cases, may actually receive the wrong treatment. For example, an estimated 46% of adults with Type 2 diabetes worldwide are undiagnosed, risking serious health complications and higher health costs. Late diagnosis of infectious diseases such as HIV and tuberculosis increases the risk of spread and makes them more difficult to treat. To address this gap, the World Health Organization (WHO) today published its first Essential Diagnostics List, a catalogue of the tests needed to diagnose the most common conditions as well as a number of global priority diseases. “An accurate diagnosis is the first step to getting effective treatment,” says Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “No one should suffer or die because of a lack of diagnostic services, o
Read more